THC
18–25%
CBD
5%
mrc (aka: meds, ready-to-cultivate) is a hybrid cannabis strain by OG Labs with up to 25% THC. Known for its balanced effects combining body relaxation and mental uplift.
No effect, terpene, flavor or medical-use data specific to mrc (aka: meds, ready-to-cultivate) has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
25% THC
About mrc (aka: meds, ready-to-cultivate)
MRC, or Meds Ready-to-Cultivate, is a hybrid boasting 25% THC and a notable 5% CBD, which amplifies its creative, euphoric, and relaxing effects to effectively address anxiety, depression, pain, and stress. Dominated by terpenes such as limonene, myrcene, and caryophyllene, it features an earthy, herbal sweetness that's soothing and approachable, making it a versatile choice for medical users. Created by OG Labs, this strain is special for its higher CBD content, providing a more balanced experience that tempers the high for a clearer, more functional headspace.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about mrc (aka: meds, ready-to-cultivate)
Is mrc (aka: meds, ready-to-cultivate) an Indica, Sativa, or Hybrid?
mrc (aka: meds, ready-to-cultivate) is classified as a hybrid cannabis strain.
What cannabinoid content is reported for mrc (aka: meds, ready-to-cultivate)?
mrc (aka: meds, ready-to-cultivate): 25% THC and 5% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.